Nadifloxacin

A new topical antibiotic cream may be emerging in the US market soon. Nadifloxacin is a new quinolone topical antibiotic in development in Japan. Nadifloxacin will come in a 0.44% cream. The DNA gyrase inhibitor has not suffered from any resistence patterns like other topical antibiotics incluing clindamycin and erythromycin.

Time will tell how this new product may be used in the fight against p. acnes and acne in general.

Add comment February 5th, 2006